SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance
10 references·1 citing·38 second hop
Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance (2008)Moral hazard in insurance, value-based co…National Health Spending In 2006: A Year Of Change For Prescription Drugs (2008)National Health Spending In 2…Value-Based Insurance Design (2007)Value-Based Insurance DesignReconsidering the moral hazard-risk avoidance tradeoff (2006)Reconsidering the moral hazar…Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Pharmacy Benefits and the Use…The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis (2003)The Cost-Effectiveness of Cyc…A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. (2001)A benefit-based copay for pre…Free for All? Lessons from the RAND Health Insurance Experiment (1995)Free for All? Lessons from th…Free for all?: lessons from the Rand Health Insurance Experiment (1994)Free for all?: lessons from t…Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives (1970)Medical insurance: A case stu…The Economics of Moral Hazard (1969)The Economics of Moral HazardPauvreté, Egalité, Mortalité: mortality (in)equality in France and the United States (2019)Pauvreté, Egalité, Mortalité:…Aspects of the Theory of Risk-Bearing. (1966)The Welfare Loss of Excess Health Insurance (1973)The Rational Nonpurchase of Long-Term-Care Insurance (1990)Reimbursing Health Plans and Health Providers: Efficiency in Production versus Selection (1996)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Unintended Consequences of Caps on Medicare Drug Benefits (2006)Patient Cost-Sharing and Hospitalization Offsets in the Elderly (2010)Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)Utility Functions that Depend on Health Status: Estimates and Economic Implications (1990)Uncertainty and The Welfare Economics of Medical Care (2001)Golden Eggs and Hyperbolic Discounting (1997)Time Discounting and Time Preference: A Critical Review (2002)Optimal health insurance for prevention and treatment (2007)What does the RAND Health Insurance Experiment tell us about the impact of patient cost sharing on health outcomes? (2008)Cost-sharing: effects on spending and outcomes. (2010)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)The impact of health care reform on hospital and preventive care: Evidence from Massachusetts (2012)Behavioral Hazard in Health Insurance * (2015)ECONOMIC CRISIS, HEALTH SYSTEMS AND HEALTH IN EUROPE: IMPACT AND IMPLICATIONS FOR POLICY (2015)American Economic Review (2019)Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction (1993)Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine (1994)10 Economics of osteoarthritis: a global perspective (1997)Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis (2009)Health insurance: The tradeoff between risk pooling and moral hazard (1996)Inequality in Quality (2000)Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer (2004)Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care (2008)Hospitalizations and Deaths Among Adults With Cardiovascular Disease Who Underuse Medications Because of Cost (2010)Community Care of North Carolina: Improving Care Through Community Health Networks (2008)Incentives for orphan drug research and development in the United States (2008)Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point (2008)The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare (2008)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)Physician Agency (2000)The Welfare State as Piggy Bank (2001)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)
this work references cited by second hop

References

  • 1995Free for All? Lessons from the RAND Health Insurance Experiment991 cited
  • 1970Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives595 cited
  • 1994Free for all?: lessons from the Rand Health Insurance Experiment584 cited
  • 1969The Economics of Moral Hazard573 cited
  • 2004Pharmacy Benefits and the Use of Drugs by the Chronically Ill530 cited
  • 2007Value-Based Insurance Design347 cited
  • 2001A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.184 cited
  • 2008National Health Spending In 2006: A Year Of Change For Prescription Drugs167 cited
  • 2003The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis121 cited
  • 2006Reconsidering the moral hazard-risk avoidance tradeoff91 cited

Cited by

  • 2019Pauvreté, Egalité, Mortalité: mortality (in)equality in France and the United States17 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work